Changes

'''Reverted to version before edits by medical contributor.'''

An '''HPV vaccine''' is a [[vaccine]] designed to prevent infection by one or more strains of [[human papillomavirus]].

An '''HPV vaccine''' is a [[vaccine]] designed to prevent infection by one or more strains of [[human papillomavirus]]. The only HPV vaccine currently on the market is Merck's Gardasil. A GlaxoSmithKline vaccine, Cervarix, is awaiting FDA approval.<ref>[http://www.vaccinerx.com/news/cervical-cancer/cervarix---glaxo-hpv-vaccine-filed-with-fda-20070330-160-26.html Cervarix - Glaxo HPV Vaccine Filed With FDA (VaccineRX)]</ref>

The HPV vaccine protects against types 6, 11, 16 and 18 of the human papillomavirus (HPV), which are sexually transmitted diseases.  These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).

 

The only HPV vaccine currently on the market is Merck's Gardasil. A GlaxoSmithKline vaccine, Cervarix, is awaiting FDA approval.<ref>[http://www.vaccinerx.com/news/cervical-cancer/cervarix---glaxo-hpv-vaccine-filed-with-fda-20070330-160-26.html Cervarix - Glaxo HPV Vaccine Filed With FDA (VaccineRX)]</ref>

Gardasil protects against types 6, 11, 16 and 18 of HPV, which are primarily sexually transmitted diseases.  These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).

Gardasil protects against types 6, 11, 16 and 18 of HPV, which are primarily sexually transmitted diseases.  These strains of HPV have been associated with 70% of cervical cancer cases and may also play a role in the development of other types of cancer <ref>[http://www.cancer.gov/cancertopics/factsheet/Risk/HPV]</ref>. In June 2006, the U.S. Food and Drug Administration approved the first HPV vaccine based on observance of elevated [[antibody]] levels in a few thousand patients who had received the vaccine (including perhaps only a few hundred or less young girls).